Pemetrexed Injection

Pemetrexed Injection

Product Details:

X

Product Description

Description :

Pemetrexed Injection 500 mg is taken into use curing malignant pleural mesothelioma in people, whose illness is unresectable; like a single agent for the primary treatment of nearby progressive or metastatic non-small cell lung cancer following prior chemotherapy; in grouping with cisplatin for curing of locally progressive or metastatic non-squamous non-small cell lung cancer; to maintain treatment of people with nearby progressive or metastatic non-squamous non-small cell lung cancer whose illness has not developed following 4 cycles of platinum built first-line chemotherapy.

Additional Information :

  • IV Suggested dose is 500 mg/m 2 infused for approximately10 min on day 1 of every 21-day cycle.

Side Effects :

  • Cardiovascular: Supraventricular arrhythmia (less than 1%).
  • CNS: Sensory neuropathy (9%); fatigue (34%); motor neuropathy (1% to 5%).
  • Dermatologic: Pruritus (7%); rash/desquamation (14%); erythema multiforme (1% to 5%), alopecia (6%).
  • EENT: Increased lacrimation, ocular surface illness comprising conjunctivitis (1% to 5%).
  • GI: Anorexia (22%); vomiting (16%); nausea (31%); diarrhea (13%); stomatitis/pharyngitis (15%); mucositis/stomatitis (7%); abdominal pain (1% to 5%); constipation (6%); colitis.
  • Genitourinary: Creatinine increased, CrCl decreased, glomerular filtration rate reduced (1% to 5%); renal failure (less than 1%).
  • Hematologic-Lymphatic: Leukopenia (12%); neutropenia (11%); anemia, thrombocytopenia (8%); febrile neutropenia (1% to 5%).
  • Hepatic: Improved ALT (10%); enlarged AST (8%).
  • Hypersensitivity: Allergic reactions/hypersensitivity (1% to 5%).
  • Respiratory: Interstitial pneumonitis.
  • Miscellaneous: Infection (5%); fever (8%); radiation recall, edema (1% to 5%).

3S CORPORATION

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.



"We mainly export our products to the foreign countries."
Back to top
3S CORPORATION All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.